This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (107)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Immunofluorescent Demonstration

Robert P. Lisak, MD; Burton Zwiman, MD; Michael Norman, MD

Arch Neurol. 1975;32(3):163-167.

Abstract
Antimyelin binding activity was determined in patients with multiple sclerosis, amyotrophic lateral sclerosis, other neurologic diseases, and normals. There was an increase in the group mean titer of antimyelin antibodies in patients with multiple sclerosis (MS) in acute exacerbation, amyotrophic lateral sclerosis (ALS) and Guillain-Barré syndrome. A lesser degree of binding was found in normals of all ages. There was an increase in the incidence of antimyelin antibodies in the IgM class in patients with ALS and MS. The interaction between human immunoglobulins and myelin seems to be immunologically specific and has the nature of an antigen-antibody reaction.

Author Affiliations
From the Department of Neurology; Division of Allergy and Immunology, Department of Medicine; and Department of Pediatrics, School of Medicine, University of Pennsylvania; and Multiple Sclerosis Research Center of the Department of Neurology of the University of Pennsylvania and the Wistar Institute.

Footnotes
Accepted for publication June 25, 1974.

Reprint requests to 3400 Spruce St, Philadelphia, PA 19174 (Dr. Lisak).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antimyelin Antibodies in Multiple Sclerosis
Maguire et al.
NEJM 2003;349:2269-2271.
FULL TEXT  

Failure of Immunosuppression With a Ten- to 14-Day Course of High-Dose Intravenous Cyclophosphamide to Alter the Progression of Amyotrophic Lateral Sclerosis
Brown et al.
Arch Neurol 1986;43:383-384.
ABSTRACT  

Antineural Antibodies in Guillain-Barre Syndrome and Lymphocytic Meningoradiculitis (Bannwarth's Syndrome)
Ryberg et al.
Arch Neurol 1984;41:1277-1281.
ABSTRACT  

Treatment of the Guillain-Barre Syndrome by Plasmapheresis
Osterman et al.
Arch Neurol 1982;39:148-154.
ABSTRACT  

Neurology
Dalessio
JAMA 1981;245:2200-2202.
ABSTRACT  

CSF Antibody to Myelin Basic Protein: Measurement in Patients With Multiple Sclerosis and Subacute Sclerosing Panencephalitis
Panitch et al.
Arch Neurol 1980;37:206-209.
ABSTRACT